Company Registration No. 05736901 (England and Wales)
Solventis Solutions Limited
Annual report and financial statements
for the year ended 31 December 2024
Solventis Solutions Limited
Company information
Directors
Michael Byrne
Russel Argo
(Appointed 3 June 2024)
Martin Gratton
(Appointed 3 June 2024)
Christopher Gilbert
Company number
05736901
Registered office
Alpha House
Lawnswood Business Park
Redvers Close
Leeds
West Yorkshire
United Kingdom
LS16 6QY
Independent auditor
Deloitte LLP
Statutory Auditors
1 City Square
Leeds
United Kingdom
LS1 2AL
Solventis Solutions Limited
Contents
Page
Strategic report
1 - 2
Directors' report
3 - 5
Independent auditor's report
6 - 8
Statement of comprehensive income
9
Statement of financial position
10
Statement of changes in equity
11
Notes to the financial statements
12 - 27
Solventis Solutions Limited
Strategic report
For the year ended 31 December 2024
1

The directors present the strategic report for the year ended 31 December 2024.

Review of the business

In this period of review the group, of which Solventis Solutions Ltd was a part, was acquired by Brenntag NV which is part of the Brenntag SE group of companies (the Brenntag Group). Shares in the UK Solventis entities were subsequently transferred to Brenntag UK Holding Limited which is also a part of the Brenntag Group.

 

The company is engaged in the automotive products industry, reselling items such as AdBlue and other oils and lubricants predominantly to the transport sectors, which are highly competitive sectors.

 

Compared to 2023, 2024 has proven to be an increasingly competitive year resulting in reduced margins. Whilst the business has shown strong revenue growth in the period this has not fully compensated for the margin reduction resulting in a net reduction in profit before tax. The directors are satisfied with the performance of the business and continue to look for areas to increase sales and maintain margins across the group. It is anticipated that, as part of the Brenntag Group, additional business opportunities will arise through cross-selling of products from the wider Brenntag portfolio and supporting existing Brenntag customers where Solventis Solutions Limited currently has no exposure.

Principal risks and uncertainties

The group's principal risks and mitigation policies are:

 

Non-payment by customers.

The company has a consistent policy of insuring trade debtors and of using other established instruments to guarantee payment and credit insurance.

 

Fluctuations in chemical prices.

The volatility of worldwide prices presents both risks and opportunities. Risk is managed by having a management structure and process that enables the company to react quickly to a movement in prices and thus contain and minimise any potential reduction in margin when prices are falling.

 

Cash flow and liquidity risk.

The business has a low exposure to cash flow and liquidity risk due to a relatively low concentration of customers. The stocks the company holds are freely traded and therefore easily converted to cash assets if required. The company's strong net asset position of £5,346,938 at 31 December 2024 and significant levels of cash and cash equivalents provide a considerable buffer against any short-term liquidity pressures and underpins the company's ability to continue to meet its liabilities as they fall due.

Key performance indicators

The company considers its key performance indicators to be:            

 

 

2024

2023

 

£

£

 

 

 

Turnover

23,768,699

19,640,480

Profit before tax

1,971,108

2,790,569

 

 

Solventis Solutions Limited
Strategic report (continued)
For the year ended 31 December 2024
2

On behalf of the board

Christopher Gilbert
Director
10 October 2025
Solventis Solutions Limited
Directors' report
For the year ended 31 December 2024
3

The directors present their annual report and financial statements for the year ended 31 December 2024.

Principal activities

The principal activity of the company continued to be that of reselling items in the automotive products industry.

Results and dividends

The results for the year are set out on page 9.

No ordinary dividends were paid (2023: £Nil). The directors do not recommend payment of a final dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

David Lubbock
(Resigned 3 June 2024)
Michael Byrne
Russel Argo
(Appointed 3 June 2024)
Martin Gratton
(Appointed 3 June 2024)
Christopher Gilbert
Qualifying third party indemnity provisions

Qualifying third party indemnity insurance was in place for the benefit of all of the directors of the company during the year and up to the date of signing the financial statements.

Post reporting date events

There have been no significant events affecting the company since the period end.

Future developments

The directors intend for the company to continue its strategy of organic growth. The directors are satisfied with the company's performance and anticipate continued success in the future through its robust strategies. There are no plans to change the company's activities in the foreseeable future.

 

Auditor

The independent auditors, Deloitte LLP, were appointed during the year and will be proposed for reappointment in accordance with section 485 of the Companies Act 2006. Deloitte LLP have expressed their willingness to continue in office.

Solventis Solutions Limited
Directors' report (continued)
For the year ended 31 December 2024
4
Statement of directors' responsibilities

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law).

 

Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

 

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Strategic report

The company has chosen in accordance with Companies Act 2006, s. 414C(11) to set out in the company's strategic report information required by Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008, Sch. 7 to be contained in the directors' report. It has done so in respect of information on exposure to credit risk, price volatility and liquidity risk and the management of these risks.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

Solventis Solutions Limited
Directors' report (continued)
For the year ended 31 December 2024
5
Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The directors have considered relevant information, including the annual budget, forecast future cash flows and the impact of subsequent events on the Group's operations. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

 

The company has access to considerable financial resources and has rigorous procedures for identifying, quantifying and mitigating all aspects of risk relevant to the business.

 

The directors have carried out a robust assessment of the risks facing both the company and the UK Group of companies of which it forms part. The directors have prepared sensitivity analysis to assess the company’s cash flows based on different scenarios including a severe downturn in the UK economy. The cashflows cover the period to 31 December 2026 and in each scenario both the company and the UK Group of companies maintain substantial liquidity.

 

In addition, the directors have received confirmation from Brenntag UK Holding Limited that financial support is in place for at least 12 months from the date of signing these financial statements.

 

As such the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis of accounting in preparing the annual financial statements.

Donations

The company made donations to charitable organisations of £nil (2023 - £nil) during the year. No political donations were made during the year (2023 - £nil).

Medium-sized companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.

Approved on behalf of the board by
Christopher Gilbert
Director
10 October 2025
Solventis Solutions Limited
Independent auditor's report
To the members of Solventis Solutions Limited
6
Report on the audit of the financial statements
Opinion

In our opinion the financial statements of Solventis Solutions Limited (the ‘company’):

 

We have audited the financial statements which comprise:

 

The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (United Kingdom Generally Accepted Accounting Practice).

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor's responsibilities for the audit of the financial statements section of our report.

 

We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the Financial Reporting Council’s (the ‘FRC’s’) Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

 

Other information

The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

 

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves.

Solventis Solutions Limited
Independent auditor's report
To the members of Solventis Solutions Limited (continued)
7

If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Responsibilities of directors

As explained more fully in the directors’ responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

 

In preparing the financial statements, the directors are responsible for assessing the company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities for the audit of the financial statements is located on the FRC’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Extent to which the audit was considered capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.

 

We considered the nature of the company’s industry and its control environment, and reviewed the company’s documentation of their policies and procedures relating to fraud and compliance with laws and regulations. We also enquired of management and the directors about their own identification and assessment of the risks of irregularities, including those that are specific to the company’s business sector.

We obtained an understanding of the legal and regulatory framework that the company operates in, and identified the key laws and regulations that:

 

We discussed among the audit engagement team regarding the opportunities and incentives that may exist within the organisation for fraud and how and where fraud might occur in the financial statements.

 

Solventis Solutions Limited
Independent auditor's report
To the members of Solventis Solutions Limited (continued)
8

In common with all audits under ISAs (UK), we are also required to perform specific procedures to respond to the risk of management override. In addressing the risk of fraud through management override of controls, we tested the appropriateness of journal entries and other adjustments; assessed whether the judgements made in making accounting estimates are indicative of a potential bias; and evaluated the business rationale of any significant transactions that are unusual or outside the normal course of business.

In addition to the above, our procedures to respond to the risks identified included the following:

Report on other legal and regulatory requirements
Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

 

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified any material misstatements in the directors’ report.

 

Matters on which we are required to report by exception

Under the Companies Act 2006 we are required to report in respect of the following matters if, in our opinion:

 

We have nothing to report in respect of these matters.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Louise Cooper FCA (Senior statutory auditor)
For and on behalf of Deloitte LLP
Statutory Auditor
Leeds, United Kingdom
10 October 2025
Solventis Solutions Limited
Statement of comprehensive income
For the year ended 31 December 2024
9
2024
2023
Notes
£
£
Turnover
3
23,768,699
19,640,480
Cost of sales
(19,129,625)
(14,905,501)
Gross profit
4,639,074
4,734,979
Distribution costs
(1,450,652)
(923,789)
Administrative expenses
(1,294,602)
(1,064,834)
Operating profit
4
1,893,820
2,746,356
Other interest receivable and similar income
8
79,754
46,775
Interest payable and similar expenses
9
(2,466)
(2,562)
Profit before taxation
1,971,108
2,790,569
Tax on profit
10
(538,357)
(659,026)
Profit for the financial year
1,432,751
2,131,543

The income statement has been prepared on the basis that all operations are continuing operations.

 

There were no recognised gains and losses for 2024 or 2023 other than those included in the statement of comprehensive income.

 

The notes on page 12 to 27 form part of these financial statements.

 

 

Solventis Solutions Limited
Statement of financial position
As at 31 December 2024
10
2024
2023
as restated
Notes
£
£
£
£
Fixed assets
Tangible assets
12
142,589
167,042
Current assets
Stocks
13
1,330,334
582,017
Debtors
14
614,284
968,513
Cash equivalents
15
4,201,775
1,967,099
Cash at bank and in hand
2,503,050
2,595,657
8,649,443
6,113,286
Creditors: amounts falling due within one year
16
(3,442,147)
(2,345,900)
Net current assets
5,207,296
3,767,386
Total assets less current liabilities
5,349,885
3,934,428
Creditors: amounts falling due after more than one year
17
-
0
(17,293)
Provisions for liabilities
Deferred taxation
20
(2,947)
(2,948)
(2,947)
(2,948)
Net assets
5,346,938
3,914,187
Capital and reserves
Called up share capital
22
100
100
Profit and loss reserves
23
5,346,838
3,914,087
Total equity
5,346,938
3,914,187

 

The financial statements were approved by the board of directors and authorised for issue on 10 October 2025 and are signed on its behalf by:
Christopher Gilbert
Director
Company Registration No. 05736901
Solventis Solutions Limited
Statement of changes in equity
For the year ended 31 December 2024
11
Called up share capital
Profit and loss reserves
Total shareholders' funds
£
£
£
As restated for the period ended 31 December 2023:
Balance at 1 January 2023
100
1,782,544
1,782,644
Year ended 31 December 2023:
Profit and total comprehensive income
-
2,131,543
2,131,543
Balance at 31 December 2023
100
3,914,087
3,914,187
Year ended 31 December 2024:
Profit and total comprehensive income
-
1,432,751
1,432,751
Balance at 31 December 2024
100
5,346,838
5,346,938

 

Solventis Solutions Limited
Notes to the financial statements
For the year ended 31 December 2024
12
1
Accounting policies
Company information

Solventis Solutions Limited is a private company limited by shares incorporated in England and Wales. The registered office is Alpha House, Lawnswood Business Park, Redvers Close, Leeds, West Yorkshire, United Kingdom, LS16 6QY.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

 

The financial statements of the company are consolidated in the financial statements of Brenntag SE. The consolidated financial statements of Brenntag SE are available at https://annualreport.brenntag.com.en/ and at their registered office, at Messeallee 11, D-45131, Essen, Germany.

Solventis Solutions Limited
Notes to the financial statements (continued)
For the year ended 31 December 2024
1
Accounting policies (continued)
13
1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The directors have considered relevant information, including the annual budget, forecast future cash flows and the impact of subsequent events on the Group's operations. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

 

The company has access to considerable financial resources and has rigorous procedures for identifying, quantifying and mitigating all aspects of risk relevant to the business.

 

The directors have carried out a robust assessment of the risks facing both the company and the UK Group of companies of which it forms part. The directors have prepared sensitivity analysis to assess the company’s cash flows based on different scenarios including a severe downturn in the UK economy. The cashflows cover the period to 31 December 2026 and in each scenario both the company and the UK Group of companies maintain substantial liquidity.

 

In addition, the directors have received confirmation from Brenntag UK Holding Limited that financial support is in place for at least 12 months from the date of signing these financial statements.

 

As such the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis of accounting in preparing the annual financial statements.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
10% straight line
Fixtures and fittings
20-33% straight line
Computers
25% straight line
Motor vehicles
25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is indication of a significant change since the last reporting date.

Solventis Solutions Limited
Notes to the financial statements (continued)
For the year ended 31 December 2024
1
Accounting policies (continued)
14
1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to net realisable value.

 

Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Solventis Solutions Limited
Notes to the financial statements (continued)
For the year ended 31 December 2024
1
Accounting policies (continued)
15
Basic financial assets

Basic financial assets, which include debtors, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Solventis Solutions Limited
Notes to the financial statements (continued)
For the year ended 31 December 2024
1
Accounting policies (continued)
16
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price after transaction costs unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

 

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

 

Where items recognised in other comprehensive income or equity are chargeable to or deductible for tax purposes, the resulting current or deferred tax expense or income is presented in the same component of comprehensive income or equity as the transaction or other event that resulted in the tax expense or income.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Solventis Solutions Limited
Notes to the financial statements (continued)
For the year ended 31 December 2024
1
Accounting policies (continued)
17
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due. Amounts not paid are shown in accruals as a liability in the statement of financial position.

1.13
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.14
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

Solventis Solutions Limited
Notes to the financial statements (continued)
For the year ended 31 December 2024
18
2
Critical accounting judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

 

The key estimations are deemed to be those in respect of the carrying value of stock and the recoverability of trade debtors.

3
Turnover

An analysis of the company's turnover is as follows:

2024
2023
£
£
Turnover analysed by class of business
Sales and delivery of chemicals
23,768,699
19,640,480
2024
2023
£
£
Turnover analysed by geographical market
United Kingdom
22,087,658
18,544,324
Europe
1,243,243
450,901
Rest of World
437,798
645,255
23,768,699
19,640,480
4
Operating profit
2024
2023
Operating profit for the year is stated after charging:
£
£
Exchange losses
153,370
93,903
Depreciation of owned tangible fixed assets
52,133
52,319
Loss on disposal of tangible fixed assets
27,904
-
Impairment of stocks recognised or reversed
67,621
-
0
Operating lease charges
60,201
2,135
Solventis Solutions Limited
Notes to the financial statements (continued)
For the year ended 31 December 2024
19
5
Auditor's remuneration
2024
2023
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the company
74,317
28,350
The appointment of auditor changed during the year from Saffery LLP to Deloitte LLP, to align with the auditor of the Brenntag group.
6
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
7
11

Their aggregate remuneration comprised:

2024
2023
£
£
Wages and salaries
502,112
503,736
Social security costs
53,329
28,649
Pension costs
12,240
11,761
567,681
544,146
7
Directors' remuneration
2024
2023
£
£
Remuneration for qualifying services
164,265
165,883
Company pension contributions to defined contribution schemes
8,620
8,225
172,885
174,108

The number of directors for whom retirement benefits are accruing under defined contribution schemes amounted to 1 (2023 - 1).

Solventis Solutions Limited
Notes to the financial statements (continued)
For the year ended 31 December 2024
20
8
Interest receivable and similar income
2024
2023
£
£
Interest income
Interest on bank deposits
79,754
-
0
Other interest income
-
0
46,775
79,754
46,775
Disclosed on the income statement as follows:
Other interest receivable and similar income
79,754
46,775
9
Interest payable and similar expenses
2024
2023
£
£
Interest on finance leases and hire purchase contracts
1,940
2,562
Other interest
526
-
0
2,466
2,562
10
Taxation
2024
2023
£
£
Current tax
UK corporation tax on profits for the current period
554,908
659,026
Adjustments in respect of prior periods
(13,925)
-
0
Total current tax
540,983
659,026
Deferred tax
Origination and reversal of timing differences
(3,510)
-
0
Adjustment in respect of prior periods
884
-
0
Total deferred tax
(2,626)
-
0
Total tax charge
538,357
659,026
Solventis Solutions Limited
Notes to the financial statements (continued)
For the year ended 31 December 2024
10
Taxation (continued)
21

The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:

2024
2023
£
£
Profit before taxation
1,971,108
2,790,569
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2023: 23.52%)
492,777
656,357
Tax effect of expenses that are not deductible in determining taxable profit
58,621
5,700
Adjustments in respect of prior years
(14,799)
-
0
Permanent capital allowances in excess of depreciation
-
0
1,463
Deferred tax adjustments in respect of prior years
(8,104)
(4,494)
Deferred tax charge
9,862
-
0
Taxation charge for the year
538,357
659,026

 

Factors that may affect future tax charges

Pillar Two legislation has been enacted and becomes effective for the financial year beginning 1 January 2024. The company has made an assessment of the effect of Pillar Two and concluded that there is no direct financial impact related to the UK entities from the introduction of the rules.

11
Impairments

Impairment tests have been carried out where appropriate and the following impairment losses have been recognised in profit or loss:

2024
2023
Notes
£
£
In respect of:
Stocks
13
67,621
-
0
Recognised in:
Cost of sales
67,621
-
Solventis Solutions Limited
Notes to the financial statements (continued)
For the year ended 31 December 2024
22
12
Tangible fixed assets
Plant and equipment
Fixtures and fittings
Computers
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 January 2024
139,515
128,945
-
0
118,535
386,995
Additions
-
0
4,185
51,399
-
0
55,584
Disposals
(108,573)
(40,474)
-
0
(40,580)
(189,627)
Transfers between classes
-
0
(56,166)
56,166
-
0
-
0
At 31 December 2024
30,942
36,490
107,565
77,955
252,952
Depreciation and impairment
At 1 January 2024
120,606
66,152
-
0
33,195
219,953
Depreciation charged in the year
6,876
8,334
14,055
22,868
52,133
Eliminated in respect of disposals
(108,573)
(40,474)
-
0
(12,676)
(161,723)
Transfers between classes
-
0
(19,009)
19,009
-
0
-
0
At 31 December 2024
18,909
15,003
33,064
43,387
110,363
Carrying amount
At 31 December 2024
12,033
21,487
74,501
34,568
142,589
At 31 December 2023
18,909
62,793
-
0
85,340
167,042
13
Stocks
2024
2023
£
£
Finished goods and goods for resale
1,330,334
582,017

As at the balance sheet date, the stock provision amounted to £133,700 (2023: £181,320).

14
Debtors
As restated
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
356,450
827,552
Corporation tax recoverable
38,271
-
0
Amounts owed by group undertakings
144,454
-
0
Other debtors
-
0
44,942
Prepayments and accrued income
73,053
96,019
612,228
968,513
Deferred tax asset (note 20)
2,056
-
0
614,284
968,513
Solventis Solutions Limited
Notes to the financial statements (continued)
For the year ended 31 December 2024
14
Debtors (continued)
23

Trading balances are receivable in line with the terms and conditions of sale (consistent with third party arrangements) and no interest is charged. Amounts owed by group undertakings are unsecured. For non-trading balances, interest is charged at market rate and repayment terms are as stated in the respective loan agreements.

Trade debtors are stated after provisions for impairment of £54,290 (2023: £Nil).

 

Cash equivalents arising from debts sold under an invoice finance agreement are presented under current asset investments.

The comparative information has been restated to reclassify balances receivable under an invoice factoring agreement from Trade Debtors to Cash Equivalents. Further information can be found in note 25.

15
Cash equivalents
As restated
2024
2023
£
£
Cash equivalents
4,201,775
1,967,099

The comparative information has been restated to reclassify balances receivable under an invoice factoring agreement from Trade Debtors to Cash Equivalents. Further information can be found in note 25.

16
Creditors: amounts falling due within one year
2024
2023
Notes
£
£
Bank loans and overdrafts
18
-
0
2,544
Obligations under finance leases
19
17,293
7,137
Trade creditors
1,665,563
1,509,267
Amounts owed to group undertakings
866,693
673,603
Taxation and social security
136,318
9,268
Other creditors
-
0
3,850
Accruals and deferred income
756,280
140,231
3,442,147
2,345,900

Finance lease obligations are secured on the assets to which they relate.

Trading balances are payable in line with the terms and conditions of sale (consistent with third party arrangements) and no interest is charged. Amounts owed to group undertakings are unsecured. For non-trading balances, interest is charged at market rate and repayment terms are as stated in the respective loan agreements.

Solventis Solutions Limited
Notes to the financial statements (continued)
For the year ended 31 December 2024
24
17
Creditors: amounts falling due after more than one year
2024
2023
Notes
£
£
Obligations under finance leases
19
-
0
17,293
18
Loans and overdrafts
2024
2023
£
£
Bank overdrafts
-
0
2,544
Payable within one year
-
0
2,544

The company is part of a Composite Company Unlimited Multilateral Guarantee dated 19 December 2019 given by Solventis Ltd, Kilfrost Europe Ltd, Solventis Europe NV, Kilfrost Europe NV, Solvenox Ltd and Solventis Solutions Ltd.

 

Security held by the bank includes a debenture including a fixed charge over non-vesting debts; First fixed charge over non-vesting debts, both present and future; and First floating charge over all assets and undertaking both present and future 10 August 2023.

 

19
Finance lease obligations
2024
2023
Future minimum lease payments due under finance leases:
£
£
Within one year
17,293
7,137
In two to five years
-
0
17,293
17,293
24,430

Finance lease payments represent rentals payable by the company for motor vehicles. Leases include purchase options at the end of the lease period, and no restrictions are placed on the use of the assets. The average lease term is 3 years. All leases are on a fixed repayment basis and no arrangements have been entered into for contingent rental payments.

 

At the year end the net carrying amount of assets under finance lease obligations is £12,801 (2023: £24,430).

Solventis Solutions Limited
Notes to the financial statements (continued)
For the year ended 31 December 2024
25
20
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:

Liabilities
Liabilities
Assets
Assets
2024
2023
2024
2023
Balances:
£
£
£
£
Accelerated capital allowances
(2,947)
(5,888)
-
-
Tax losses
-
2,940
-
-
Pensions
-
-
2,056
-
(2,947)
(2,948)
2,056
-
2024
Movements in the year:
£
Liability at 1 January 2024
(2,948)
Asset balances offset
2,057
Liability at 31 December 2024
(891)

The deferred tax asset set out above is expected to reverse within 12 months and relates to short term timing differences impacting taxable income.  The deferred tax liability set out above relates to accelerated capital allowances and this position is expected to reverse within 12 months.

 

 

 

21
Retirement benefit schemes
2024
2023
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
12,240
11,761

The company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. Contributions totalling £nil (2023- £nil) were payable to the fund at the balance sheet date.

22
Called up share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary Shares of 10p each
1,000
1,000
100
100
Solventis Solutions Limited
Notes to the financial statements (continued)
For the year ended 31 December 2024
26
23
Profit and loss reserves

The profit and loss account reserve includes all current and prior period retained profits and losses.

24
Related party transactions

 

The company is exempt under FRS 102 from disclosing related party transactions with members of the same group that are wholly owned. The transactions with entities under common control in the 5 month period prior to the acquisition by Brenntag NV are disclosed below.

 

The company made sales of £84,822 (2023: full year £368,798) and purchases of £1,764,850 (2023: full year £3,073,661) with Solventis Limited.

 

The company made sales of £71,295 (2023: full year £77,151) and purchases of £481,661 (2023: full year £615,867) with Solvenox Limited.

25
Prior period adjustment
Changes to the statement of financial position
As previously reported
Adjustment
As restated at 31 Dec 2023
£
£
£
Current assets
Debtors due within one year
2,935,612
(1,967,099)
968,513
Cash equivalents
-
1,967,099
1,967,099
Net assets
3,914,187
-
3,914,187
Capital and reserves
Total equity
3,914,187
-
3,914,187
Reconciliation of changes in equity
The prior period adjustments do not give rise to any effect upon equity.
Notes to reconciliation
Non-recourse debtors

In the prior year, a balance of £1,967,099 of cash equivalents arising from debts sold under an invoice finance agreement were included in current assets under debtors. These have been restated and are now presented under current assets (cash equivalents). The accounts have been restated to correct the comparative figures in Cash Equivalents and Trade Debtors as above, with no impact on the income statement.

Solventis Solutions Limited
Notes to the financial statements (continued)
For the year ended 31 December 2024
27
26
Ultimate controlling party

The company’s immediate parent company is FCL Organisation Limited which is registered in the United Kingdom.

 

On 3 June 2024, the Company's ultimate parent at that date, Solventis Limited, was acquired by Brenntag NV, which is part of the Brenntag SE group of companies.

 

On 14 June 2024, shares in Solventis Limited were transferred by Brenntag NV to Brenntag UK Holding Limited, which is also part of the Brenntag SE group of companies.

The Company’s ultimate parent company and controlling entity is Brenntag SE which is incorporated in Germany.

Brenntag SE is the parent undertaking of the smallest and largest group to consolidate these financial statements at 31 December 2024. The consolidated financial statements of Brenntag SE are available at their registered office, at Messeallee 11, D-45131, Essen, Germany.

2024-12-312024-01-01falsefalsefalseCCH SoftwareCCH Accounts Production 2024.301David LubbockMichael ByrneRussel ArgoMartin GrattonChristopher Gilbert057369012024-01-012024-12-3105736901bus:Director22024-01-012024-12-3105736901bus:Director32024-01-012024-12-3105736901bus:Director42024-01-012024-12-3105736901bus:Director52024-01-012024-12-3105736901bus:Director12024-01-012024-12-3105736901bus:RegisteredOffice2024-01-012024-12-31057369012024-12-31057369012023-01-012023-12-3105736901core:RetainedEarningsAccumulatedLosses2023-01-012023-12-3105736901core:RetainedEarningsAccumulatedLosses2024-01-012024-12-31057369012023-12-3105736901core:PlantMachinery2024-12-3105736901core:FurnitureFittings2024-12-3105736901core:ComputerEquipment2024-12-3105736901core:MotorVehicles2024-12-3105736901core:PlantMachinery2023-12-3105736901core:FurnitureFittings2023-12-3105736901core:ComputerEquipment2023-12-3105736901core:MotorVehicles2023-12-3105736901core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3105736901core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3105736901core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3105736901core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-3105736901core:CurrentFinancialInstruments2024-12-3105736901core:CurrentFinancialInstruments2023-12-3105736901core:ShareCapital2024-12-3105736901core:ShareCapital2023-12-3105736901core:RetainedEarningsAccumulatedLosses2024-12-3105736901core:RetainedEarningsAccumulatedLosses2023-12-3105736901core:ShareCapital2022-12-3105736901core:RetainedEarningsAccumulatedLosses2022-12-3105736901core:PlantMachinery2024-01-012024-12-3105736901core:FurnitureFittings2024-01-012024-12-3105736901core:ComputerEquipment2024-01-012024-12-3105736901core:MotorVehicles2024-01-012024-12-310573690112024-01-012024-12-310573690112023-01-012023-12-3105736901core:UKTax2024-01-012024-12-3105736901core:UKTax2023-01-012023-12-3105736901core:PlantMachinery2023-12-3105736901core:FurnitureFittings2023-12-3105736901core:ComputerEquipment2023-12-3105736901core:MotorVehicles2023-12-31057369012023-12-3105736901core:CurrentFinancialInstrumentscore:UnlistedNon-exchangeTraded2024-12-3105736901core:CurrentFinancialInstrumentscore:UnlistedNon-exchangeTraded2023-12-3105736901core:Non-currentFinancialInstruments2024-12-3105736901core:Non-currentFinancialInstruments2023-12-3105736901core:WithinOneYear2024-12-3105736901core:WithinOneYear2023-12-3105736901core:BetweenTwoFiveYears2024-12-3105736901core:BetweenTwoFiveYears2023-12-3105736901bus:PrivateLimitedCompanyLtd2024-01-012024-12-3105736901bus:FRS1022024-01-012024-12-3105736901bus:Audited2024-01-012024-12-3105736901bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP